Candel Therapeutics, Inc. (CADL) Financials
CADL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 50.1 million | 27.0 million |
| 2023-06-30 | 58.7 million | 27.9 million |
| 2023-03-31 | 67.2 million | 27.6 million |
| 2022-12-31 | 77.7 million | 30.0 million |
CADL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -8.9 million | 686000 |
| 2023-06-30 | -7.4 million | 733000 |
| 2023-03-31 | -11.0 million | 733000 |
| 2022-12-31 | -7.2 million | 634000 |
CADL Net Income
No data available :(
CADL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 43.0 million | - | 1.6 million |
| 2023-06-30 | 51.9 million | - | 1.7 million |
| 2023-03-31 | 59.3 million | 19.7 million | 1.8 million |
| 2022-12-31 | 70.1 million | - | 2.0 million |
CADL Shares Outstanding
CADL Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 103000 | 5.8 million | 3.0 million | - |
| 2023-06-30 | 169000 | 5.9 million | 3.6 million | - |
| 2023-03-31 | 138000 | 5.5 million | 4.2 million | - |
| 2022-12-31 | 276000 | 5.0 million | 3.2 million | - |
CADL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 306000 |
| 2023-06-30 | - | 295000 |
| 2023-03-31 | - | 287000 |
| 2022-12-31 | 31000 | 276000 |
CADL
Price: $9.02
52 week price:
Earnings Per Share: -1.31 USD
P/E Ratio: -1.54
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 14500
Market Capitalization: 195.5 million